Skip to search formSkip to main contentSkip to account menu

Arimidex

Known as: Astra brand of anastrozole, AstraZeneca brand of anastrozole, Zeneca brand of anastrozole 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

anastrozole
anastrozole 1 MG Oral Tablet [Arimidex]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The ATAC adjuvant breast-cancer trial: Six-year results of the endometrial subprotocol
Postmenopausal women with localised, early breast cancer (n = 285) were enrolled in a prospective subprotocol of the ‘arimidex… 
2009
2009
Results of randomized phase II trial combining Iressa® (gefitinib) and arimidex in women with advanced breast cancer (ABC). EORTC protocol 10021.
CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts Abstract #6133 Background: Preclinical data suggest that EGFR… 
Review
2008
Review
2008
Clinical trial presentations, agency guidelines, and oncology practice: findings from the arimidex, tamoxifen, alone or in combination trial.
PURPOSE Our objective was to explore the potential influence of agency guidelines/technology assessments regarding anastrozole… 
Review
2003
Review
2003
Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study).
  • J. Cuzick
  • Recent results in cancer research. Fortschritte…
  • 2003
  • Corpus ID: 36779827
Current prevention trials have shown that tamoxifen can reduce the incidence of breast cancer by about 30%-40% in high-risk women… 
2002
2002
Aromatase inhibitors in breast cancer
Review
2001
Review
2001
Anastrozole (Arimidex ™) – an aromatase inhibitor for the adjuvant setting?
Anastrozole (Arimidex™) is a third-generation aromatase inhibitor which has been shown to possess superior efficacy and… 
2001
2001
Combined use of goserelin (zoladex) and anastrozole (arimidex) as second-line endocrine therapy in premenopausal women with advanced breast cancer — a study of its clinical and endocrine effects
2000
2000
Gonadotropins Stimulate Growth of MCF-7 Human Breast Cancer Cells by Promoting Intracellular Conversion of Adrenal Androgens to Estrogens
Estrogen receptor (ER)-positive breast cancers initially respond well to estrogen ablation treatment but finally acquire… 
1998
1998
Effect of dual inhibition of 5‐alpha‐reductase and aromatase on spontaneously developed canine prostatic hypertrophy
Our aim was to assess the effect of dual inhibition of 5‐alpha‐reductase and aromatase on prostate glands. 
1996
1996
Aromatase inhibition for breast cancer treatment.
While the first generation aromatase inhibitor aminoglutethimide and second- and third generation inhibitors like formestane and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)